The US Sun

A SINGLE-dose nasal spray treatment could 'wash away' build ups of toxic proteins associated with Alzheimer’s disease from brain cells and improve memory, scientists say. The study - performed on mice - paves the way for new treatments against Alzheimer's and dementia, researchers at the University of Texas Medical Branch said.

Single-dose nasal spray ‘washes the brain’ of toxic Alzheimer’s proteins – paving the way for breakthrough treatment

Minnesota State

Fox News

Scientists at Mayo Clinic say they have identified a new type of memory loss that is very similar to Alzheimer’s disease, but doesn’t progress as quickly and has a “better prognosis."

Mayo Clinic finds new type of memory loss that’s often mistaken for Alzheimer’s

Recent advancements in medical research have introduced a blood test that can diagnose Alzheimer's disease with a remarkable 90% accuracy rate, potentially transforming how the disease is detected and managed. This innovative diagnostic tool, highlighted in a recent study involving 1,213 patients in Sweden, has shown significantly higher accuracy compared...

Revolutionary Blood Tests for Alzheimer’s: A Breakthrough in Early Diagnosis

Visual hallucinations are a significant issue for many patients with Parkinson’s disease. A recent study published in the journal Brain reveals that these hallucinations are associated with a marked deficiency of cholinergic activity in specific regions of the brain, particularly the left ventral visual stream and the left superior temporal lobe. This research highlights the importance of cholinergic denervation in visual hallucinations, offering new insights into the underlying mechanisms and potential treatment options.

Visual hallucinations in Parkinson’s disease linked to cholinergic deficiency

Mens Journal

It all depends on how your body distributes it.

Study Finds Link Between Alzheimer's and Fat in Certain Parts of Body

The Mirror US

Although there is currently no known cure for Alzheimer's, there are treatments that can lessen its symptoms, including disorientation and memory loss, and some may even stop the disease's progression

New Alzheimer's treatment could reverse brain disease and restore memory, study finds

Researchers at Mayo Clinic have established new criteria for a memory-loss syndrome in older adults that speciﬁcally impacts the brain's limbic system. It can often be mistaken for Alzheimer disease. However, limbic-predominant Amnestic Neurodegenerative Syndrome, or LANS, progresses more slowly and has a better prognosis, and is now more clearly deﬁned for doctors working to ﬁnd answers for memory loss patients.

Mayo Clinic Researchers Define New Memory Loss Syndrome

The early signs of dementia in women include memory loss and confusion. Dementia is a collective term that describes various symptoms of cognitive decline, such as forgetfulness, confusion, and changes in behavior. It is not a specific disease but a group of conditions characterized by impairment of at least two brain functions, such as memory loss and judgment.

Early signs of dementia in women

North Carolina State

Community Voices represent independent, third-party users who have joined our contributor program but not yet verified their accounts. Community Voices are expected, like all users, to adhere to our Community Standards.

community_voice

Town Talks

In North Carolina, the divorce process can be challenging, particularly due to the mandatory one-year separation requirement. This law mandates that couples must live separately for at least a year before filing for divorce, a rule that can be frustrating for many.

You might be granted a divorce in North Carolina if your spouse is ‘incurably insane.’ Here’s how

The use of Montelukast oral film, an experimental therapy being repurposed by Intelgenx to treat mild to moderate Alzheimer’s disease, led to significant improvements in patients’ cognition versus a placebo in a Phase 2 clinical trial. That’s according to the findings of a top-line analysis of efficacy data...

Montelukast oral film may help in mild to moderate Alzheimer’s

The New York Times

The Food and Drug Administration on Tuesday approved a new drug for Alzheimer’s disease, the latest in a novel class of treatments that has been greeted with hope, disappointment and skepticism.

New Drug Approved for Early Alzheimer’s

Blood tests that can detect 90% of Alzheimer’s cases could revolutionize access to Alzheimer’s treatment, studies say.

Alzheimer’s blood test catches 90% of early dementia cases, study finds

Contributors represent independent, third-party users who have joined our contributor program and self-verified their accounts. They have also demonstrated their experience writing hard news for other outlets. Contributors are expected, like all users, to adhere to our Community Standards.

contributor

The Current GA

Since 2020, the condition known as long COVID-19 has become a widespread disability affecting the health and quality of life of millions of people across the globe and costing economies billions of dollars in reduced productivity of employees and an overall drop in the work force .

Expert: Long COVID puzzle pieces are falling into place – picture is unsettling

Hiking isn’t for everyone. It’s a beautiful pastime, but it requires tenacity and a consistent mode of transportation. At the very least, it can be one of the cheapest ways to experience that elusive sense of verdant peace. With the MO/GO exoskeleton hiking pants, a traipse through the mountains is becoming more mechanical, not to mention expensive. For this pair of turbo-fied trousers, you’ll need to pony up $4,500 if you get in early. Later, it will cost you a cool $5,000.

$5,000 Exoskeleton Pants Promise to Make You a Better Hiker

Positive trial results show the specialized cell product achieved an overall slowing of disease worsening compared to placebo. Lomecel-B, a living cell product for the treatment of Alzheimer’s Disease, has met key primary and secondary endpoints in the Phase IIa CLEAR MIND clinical trial (NCT05233774). Among emerging, positive results from the study, Longeveron’s potential therapy showed an overall slowing of disease worsening compared to placebo.1.

Lomecel-B Meets Key Objectives in Phase IIa Alzheimer’s Study

USA TODAY

A new generation of blood tests could accelerate Alzheimer's diagnosis and improve treatment for millions of older Americans.

How a new blood test technology could change Alzheimer's treatment forever

I’ve always adored cinnamon. Its aroma warms the cockles of my heart, and its flavor makes me feel as if I’m wrapped up in an old fairy tale. However, I was floored when I reviewed some of the latest research regarding the effects of cinnamon on brain health.

Cinnamon versus brain cancer, Alzheimer’s disease, and insomnia

Queen City News

A blood test can determine whether memory loss is caused by Alzheimer’s disease with more than 90 percent accuracy, according to a new study published Sunday.

Blood test has a 90 percent accuracy rate in determining whether memory loss is due to Alzheimer’s: Study

Researchers at the Mayo Clinic have drafted new criteria for a memory-loss disorder that bears similarities with Alzheimer's yet has a better prognosis. The corresponding article was published in Brain Communications. "This research creates a precise framework that other medical professionals can use to care for their patients. It has...

New Memory Loss Disorder that Mimics Alzheimer's Identified

Two recent developments in Alzheimer’s disease research offer new hope for patients living with the disease, and their families. Among those, in June, Tiziana Life Sciences received Food and Drug Administration clearance to use intranasal foralumab in its first patient with moderate Alzheimer’s disease under the FDA’s expanded access investigational new drug program.

FDA clears nasal spray for moderate Alzheimer’s disease in first patient

NewsBreak

Blood Test Shows Promise for Alzheimer’s Diagnosis

A simple blood test shows promise as a way to detect Alzheimer’s disease, which could drastically improve the accuracy and speed of diagnoses. Currently, Alzheimer’s is...

Blood Test Shows Promise for Alzheimer’s Diagnosis

Comments / 0